Uqba Khan - Concepedia

Concepedia

Author

Uqba Khan

Cornell University ORCID

Also Known As

Uqba Khan

70

Publications

1.4K

Citations

20

H-Index

57

Concepts

All Affiliations

Cornell University Presbyterian Hospital New York Hospital Queens NewYork–Presbyterian Hospital Weill Cornell Medicine

UK

About

Uqba Khan is an author at Cornell University specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	219
2	Health Sciences	4	4	154
3	Public Health	1	1	11
4	Cell Biology	1	1	12
5	Cellular Physiology	1	1	12

Uqba Khan

×

22

Publications

854

Citations

17

H-Index

	Year	Citations
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma Ambreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri, Cancers	2021	78
Immunotherapy-associated autoimmune hemolytic anemia Uqba Khan, Farman Ali, Muhammad Khurram, Journal for ImmunoTherapy of Cancer	2017	74
Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade David J. Pinato, Takahiro Kaneko, Anwaar Saeed, Cancers	2020	74
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study Brett Marinelli, Edward Kim, Antonio D’Alessio, Journal for ImmunoTherapy of Cancer	2022	67
Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice David J. Pinato, Thomas U. Marron, Pallavi S. Mishra‐Kalyani, European Journal of Cancer HepatologyLandmark Clinical TrialsMedicineImmunologyClinical Trials	2021	62
Nivolumab induced myxedema crisis Uqba Khan, Humaira Rizvi, Dahlia Sano, Journal for ImmunoTherapy of Cancer	2017	59
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study Petros Fessas, Ahmed O. Kaseb, Yinghong Wang, Journal for ImmunoTherapy of Cancer PathologyPost-registration ExperienceOncologyInternational StudyBackground Nivolumab	2020	59
Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma Petros Fessas, Muntaha Naeem, Matthias Pinter, Liver Cancer	2021	59
Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer Pashtoon Murtaza Kasi, Manuel Hidalgo, Mehraneh D. Jafari, Oncogene	2023	37
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy David J. Pinato, Ahmed O. Kaseb, Yinghong Wang, Journal for ImmunoTherapy of Cancer	2020	35

Page 1